Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
PHIO PHARMACEUTICALS CORP.
AI Executive Summary
AI-powered analysis of 8-K filing content
Phio Pharmaceuticals secured $6.36 million in capital through an At The Market Offering Agreement with H.C. Wainwright & Co., providing flexible funding to support ongoing operations and development initiatives.
Key Takeaways
Company entered into an ATM offering agreement allowing sale of up to $6.36 million in common stock
Capital raise provides flexible funding mechanism to support operational and development needs without fixed timeline
2 more takeaways
Related Filings (2)
2 more filings from PHIO PHARMACEUTICALS CORP. in the last 90 days